BRK-B vs CET
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CET presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 5/9 and a massive valuation gap, with a Graham Number of $111.61 and Intrinsic Value of $269.93 against a current price of $53.05. The company maintains a pristine balance sheet with zero debt and strong historical growth, though it is currently facing a severe bearish technical trend (10/100). While the current P/E of 5.80 is highly attractive, the anomalous Forward P/E and profit margin figures suggest potential accounting volatility or one-time events. Overall, the fundamental safety margin provided by the book value and dividend sustainability outweighs the short-term technical weakness.
Compare Another Pair
Related Comparisons
BRK-B vs CET: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Central Securities Corporation (CET) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.